FDA approves Tonix’s Tonmya to treat fibromyalgia
The approval was based on data from two Phase III clinical trials with 1,000 participants.
Approvals
BeOne Medicines’ BTK degrader gains EMA PRIME designation
EC approves argenx’s efgartigimod alfa for CIDP treatment
Novartis’ ribociclib approved in Canada for early breast cancer
Tisento’s MELAS treatment receives fast track status from FDA
Averoa secures EC authorisation for oral CKD treatment
FDA approves MSD’s Keytruda to treat head and neck cancer
FDA approves label expansion of AbbVie hepatitis C therapy
